| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harrow, Inc. (HROW) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. HROW is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.07M | $118.43M | - | |
| CFO | 837.8K | $32.36M | - | |
| 10% | 70.0K | $2.70M | - | |
| Other | 30.0K | $1.16M | - | |
| Other | 15.0K | $579.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Opaleye Management Inc.59 | 10% Owner | Buy | 29,400 | $10.56 | $310,390.50 | +0.8% | +135.3% | +122.4% | |
| Mar 28, 2024 | Opaleye Management Inc.59 | 10% Owner | Buy | 50,000 | $12.82 | $641,000.00 | +1.4% | +61.3% | +98.1% | |
| Mar 22, 2024 | Baum Mark L66 | Chief Executive Officer | Buy | 9,000 | $11.59 | $104,310.00 | +0.4% | +73.3% | +147.0% | |
| Mar 20, 2024 | Opaleye Management Inc.59 | 10% Owner | Buy | 50,600 | $9.65 | $488,290.00 | +1.4% | +67.8% | +167.0% | |
| Nov 16, 2023 | Baum Mark L66 | Chief Executive Officer | Buy | 7,500 | $8.11 | $60,825.00 | +0.4% | +33.6% | +353.6% | |
| Nov 15, 2023 | Opaleye Management Inc.59 | 10% Owner | Buy | 25,000 | $8.03 | $200,735.00 | +0.7% | +42.1% | +429.1% | |
| Sep 20, 2023 | Opaleye Management Inc.59 | 10% Owner | Buy | 20,000 | $14.60 | $292,076.29 | +0.3% | -28.7% | +228.4% | |
| Aug 14, 2023 | Baum Mark L66 | Chief Executive Officer | Buy | 5,800 | $17.05 | $98,890.00 | +0.3% | -25.8% | +119.0% | |
| Aug 14, 2023 | Makary Martin A. | Director | Buy | 20,000 | $16.92 | $338,400.00 | +80.0% | -25.8% | +119.0% | |
| Dec 22, 2022 | Baum Mark L66 | Chief Executive Officer | Buy | 25,000 | $13.39 | $334,750.00 | +1.8% | +28.0% | -21.6% |